For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250708:nRSH1754Qa&default-theme=true
RNS Number : 1754Q Arada Sukuk 2 Limited 08 July 2025
NOT FOR DISTRIBUTION: (A) IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN,
THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE
U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN
MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA)
(THE "UNITED STATES") OR TO ANY U.S. PERSON (AS DEFINED BELOW); OR (B) IN OR
INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.
8 July 2025
ARADA SUKUK 2 LIMITED ANNOUNCES RESULTS OF CONSENT SOLICITATION
to eligible holders of its outstanding
U.S.$ 550,000,000 Trust Certificates due 2029
(the "Certificates")
ARADA SUKUK 2 LIMITED
(Incorporated as an exempted company with limited liability in the Cayman
Islands)
(the "Trustee")
Description of Certificates Aggregate Face Amount Outstanding Consent Fee
ISIN
U.S.$ 550,000,000 Certificates due 2029 U.S.$ 550,000,000 XS2841181972 U.S.$ 0.75 per U.S.$ 1,000
in aggregate face
amount of the
Certificates
On 16 June 2025, the Trustee announced an invitation to holders of the
Certificates to consent to certain modifications of the terms and conditions
of the Certificates and the documents relating to the Certificates, all as
further described in the consent solicitation memorandum dated 16 June 2025
(the "Consent Solicitation Memorandum"). Capitalised terms used in this notice
and not otherwise defined shall have the meanings given to them in the Consent
Solicitation Memorandum.
Results of Consent Solicitation at the Consent Fee Deadline and the Expiration
Deadline
Valid Electronic Voting Instructions voting in favour of the Extraordinary
Resolution representing less than 50 per cent. in aggregate face amount of
each of the Certificates outstanding were provided by Eligible
Certificateholders to the Information and Tabulation Agent as at both the
Consent Fee Deadline and the Expiration Deadline. Consequently, as at each of
the Consent Fee Deadline and the Expiration Deadline, Electronic Consent has
not been granted and the Extraordinary Resolution has not been duly passed.
A Meeting will be held at the offices of Greenberg Traurig, LLP at The Shard,
Level 8, 32 London Bridge Street, London SE1 9SG, United Kingdom at 10.15 a.m.
(London time) on 9 July 2025 for the purpose of considering and, if thought
fit, passing the Extraordinary Resolution.
Further details about the Consent Solicitation can be obtained from:
The Solicitation Agent
Standard Chartered Bank
7th Floor Building One, Gate Precinct
Dubai International Financial Centre
P.O. Box 999
Dubai
United Arab Emirates
Attention: Liability Management
Email: liability_management@sc.com
The Information and Tabulation Agent
Sodali & Co Ltd
The Leadenhall Building
122 Leadenhall Street
London
EC3V 4AB
United Kingdom
Email: arada@investor.sodali.com (mailto:arada@investor.sodali.com)
Transaction Website: https://projects.sodali.com/arada
(https://projects.sodali.com/arada)
Distribution Restrictions
This announcement and the Consent Solicitation Memorandum do not constitute an
offer or an invitation to participate in the Consent Solicitation in any
jurisdiction in or from which, or to or from any person to or from whom, it is
unlawful to make such offer or invitation under applicable securities laws.
The distribution of the Consent Solicitation Memorandum in certain
jurisdictions may be restricted by law. Persons into whose possession the
Consent Solicitation Memorandum comes are required by each of the Trustee,
Arada, the Solicitation Agent, the Delegate and the Information and Tabulation
Agent to inform themselves about, and to observe, any such restrictions.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCRPMPTMTTMMIA